<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Formulation development of a fixed dose combination tablets of metformin and pregabalin</title>
  </titleInfo>
  <name type="personal">
    <namePart>Nosheen Rafaqat (5955)</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="text">Islamabad</placeTerm>
    </place>
    <publisher>(unpublished)</publisher>
    <dateIssued>2022</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <physicalDescription>
    <extent>xviii, 100 p. : ill. ; 30 cm. +CD</extent>
  </physicalDescription>
  <note>Submitted in fulfillment of the requirement for the degree of Master of Philosophy to the Faculty of Pharmaceutical Sciences.</note>
  <note>Includes bibliographical references.</note>
  <note>Thesis supervisor: Dr. Shahiq-uz-Zaman
Co-supervisor: Dr. Amna Niaz</note>
  <note>Thesis (M.Phil)--Riphah International University, 2022</note>
  <note>English</note>
  <subject>
    <topic>Pharmaceutics</topic>
    <topic>Diabetes mellitus</topic>
    <topic>Pathophysiology</topic>
    <topic>Pharmacokinetics</topic>
    <topic>Pregabalin</topic>
    <topic>RIPS</topic>
  </subject>
  <classification authority="ddc">615.1 NOS</classification>
  <recordInfo>
    <recordContentSource authority="marcorg"/>
  </recordInfo>
</mods>
